nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—Epirubicin—urinary bladder cancer	0.656	1	CbGbCtD
Carbachol—CHRM3—ureter—urinary bladder cancer	0.0315	0.267	CbGeAlD
Carbachol—CHRM3—muscle of abdomen—urinary bladder cancer	0.0227	0.192	CbGeAlD
Carbachol—Venous thrombosis—Carboplatin—urinary bladder cancer	0.00957	0.0436	CcSEcCtD
Carbachol—Gastrointestinal ulcer haemorrhage—Fluorouracil—urinary bladder cancer	0.00833	0.038	CcSEcCtD
Carbachol—Fluid overload—Carboplatin—urinary bladder cancer	0.0083	0.0378	CcSEcCtD
Carbachol—Gastrointestinal ulcer haemorrhage—Cisplatin—urinary bladder cancer	0.0079	0.036	CcSEcCtD
Carbachol—CHRNA2—prostate gland—urinary bladder cancer	0.00756	0.0641	CbGeAlD
Carbachol—PLA2G4A—Raltitrexed—Methotrexate—urinary bladder cancer	0.00624	1	CbGdCrCtD
Carbachol—PLA2G4A—prostate gland—urinary bladder cancer	0.00612	0.0518	CbGeAlD
Carbachol—Extravasation—Carboplatin—urinary bladder cancer	0.00592	0.027	CcSEcCtD
Carbachol—PLA2G4A—seminal vesicle—urinary bladder cancer	0.00517	0.0439	CbGeAlD
Carbachol—Necrosis—Mitomycin—urinary bladder cancer	0.00489	0.0223	CcSEcCtD
Carbachol—Stinging—Mitomycin—urinary bladder cancer	0.00474	0.0216	CcSEcCtD
Carbachol—CHRM2—prostate gland—urinary bladder cancer	0.00451	0.0382	CbGeAlD
Carbachol—Extravasation—Mitomycin—urinary bladder cancer	0.0044	0.0201	CcSEcCtD
Carbachol—Phlebitis—Carboplatin—urinary bladder cancer	0.00435	0.0198	CcSEcCtD
Carbachol—Gastrointestinal ulcer haemorrhage—Methotrexate—urinary bladder cancer	0.00434	0.0197	CcSEcCtD
Carbachol—PLA2G4A—smooth muscle tissue—urinary bladder cancer	0.00433	0.0367	CbGeAlD
Carbachol—PLA2G4A—renal system—urinary bladder cancer	0.00417	0.0353	CbGeAlD
Carbachol—CHRM1—prostate gland—urinary bladder cancer	0.0041	0.0348	CbGeAlD
Carbachol—PLA2G4A—urethra—urinary bladder cancer	0.0041	0.0347	CbGeAlD
Carbachol—Ulcer—Mitomycin—urinary bladder cancer	0.00406	0.0185	CcSEcCtD
Carbachol—CHRM3—prostate gland—urinary bladder cancer	0.00367	0.0311	CbGeAlD
Carbachol—PLA2G4A—female reproductive system—urinary bladder cancer	0.00334	0.0283	CbGeAlD
Carbachol—PLA2G4A—vagina—urinary bladder cancer	0.00302	0.0256	CbGeAlD
Carbachol—Venous thrombosis—Cisplatin—urinary bladder cancer	0.00281	0.0128	CcSEcCtD
Carbachol—CHRM3—smooth muscle tissue—urinary bladder cancer	0.0026	0.022	CbGeAlD
Carbachol—CHRM3—renal system—urinary bladder cancer	0.0025	0.0212	CbGeAlD
Carbachol—CHRM3—urethra—urinary bladder cancer	0.00246	0.0208	CbGeAlD
Carbachol—Fluid overload—Cisplatin—urinary bladder cancer	0.00244	0.0111	CcSEcCtD
Carbachol—Flatulence—Valrubicin—urinary bladder cancer	0.0024	0.0109	CcSEcCtD
Carbachol—CHRM1—female reproductive system—urinary bladder cancer	0.00224	0.019	CbGeAlD
Carbachol—Extravasation—Thiotepa—urinary bladder cancer	0.00221	0.0101	CcSEcCtD
Carbachol—Necrosis—Fluorouracil—urinary bladder cancer	0.00204	0.00927	CcSEcCtD
Carbachol—CHRM3—female reproductive system—urinary bladder cancer	0.002	0.017	CbGeAlD
Carbachol—Stinging—Fluorouracil—urinary bladder cancer	0.00197	0.00898	CcSEcCtD
Carbachol—PLA2G4A—lymph node—urinary bladder cancer	0.00195	0.0166	CbGeAlD
Carbachol—Necrosis—Cisplatin—urinary bladder cancer	0.00193	0.00879	CcSEcCtD
Carbachol—Abscess—Cisplatin—urinary bladder cancer	0.00191	0.00872	CcSEcCtD
Carbachol—Eye irritation—Fluorouracil—urinary bladder cancer	0.00187	0.00852	CcSEcCtD
Carbachol—Extravasation—Gemcitabine—urinary bladder cancer	0.00186	0.00848	CcSEcCtD
Carbachol—Tenderness—Gemcitabine—urinary bladder cancer	0.00186	0.00848	CcSEcCtD
Carbachol—Tenderness—Fluorouracil—urinary bladder cancer	0.00183	0.00834	CcSEcCtD
Carbachol—Extravasation—Fluorouracil—urinary bladder cancer	0.00183	0.00834	CcSEcCtD
Carbachol—Infection—Carboplatin—urinary bladder cancer	0.00183	0.00834	CcSEcCtD
Carbachol—Necrosis—Etoposide—urinary bladder cancer	0.00177	0.00805	CcSEcCtD
Carbachol—Tenderness—Cisplatin—urinary bladder cancer	0.00174	0.00791	CcSEcCtD
Carbachol—Extravasation—Cisplatin—urinary bladder cancer	0.00174	0.00791	CcSEcCtD
Carbachol—Ulcer—Gemcitabine—urinary bladder cancer	0.00172	0.00783	CcSEcCtD
Carbachol—Ulcer—Fluorouracil—urinary bladder cancer	0.00169	0.00769	CcSEcCtD
Carbachol—Ulcer—Cisplatin—urinary bladder cancer	0.0016	0.00729	CcSEcCtD
Carbachol—Extravasation—Etoposide—urinary bladder cancer	0.00159	0.00724	CcSEcCtD
Carbachol—Pain—Carboplatin—urinary bladder cancer	0.00158	0.00718	CcSEcCtD
Carbachol—Abdominal pain—Valrubicin—urinary bladder cancer	0.00157	0.00716	CcSEcCtD
Carbachol—Body temperature increased—Valrubicin—urinary bladder cancer	0.00157	0.00716	CcSEcCtD
Carbachol—Syncope—Mitomycin—urinary bladder cancer	0.00151	0.00686	CcSEcCtD
Carbachol—Hyperkalaemia—Cisplatin—urinary bladder cancer	0.00149	0.00678	CcSEcCtD
Carbachol—Loss of consciousness—Mitomycin—urinary bladder cancer	0.00148	0.00672	CcSEcCtD
Carbachol—Ulcer—Etoposide—urinary bladder cancer	0.00147	0.00668	CcSEcCtD
Carbachol—Body temperature increased—Carboplatin—urinary bladder cancer	0.00146	0.00663	CcSEcCtD
Carbachol—Venous thrombosis—Epirubicin—urinary bladder cancer	0.00144	0.00656	CcSEcCtD
Carbachol—Diarrhoea—Valrubicin—urinary bladder cancer	0.00136	0.0062	CcSEcCtD
Carbachol—Shock—Mitomycin—urinary bladder cancer	0.00135	0.00614	CcSEcCtD
Carbachol—Venous thrombosis—Doxorubicin—urinary bladder cancer	0.00133	0.00607	CcSEcCtD
Carbachol—Dizziness—Valrubicin—urinary bladder cancer	0.00132	0.00599	CcSEcCtD
Carbachol—Phlebitis—Cisplatin—urinary bladder cancer	0.00128	0.00581	CcSEcCtD
Carbachol—Vomiting—Valrubicin—urinary bladder cancer	0.00126	0.00576	CcSEcCtD
Carbachol—Rash—Valrubicin—urinary bladder cancer	0.00125	0.00571	CcSEcCtD
Carbachol—Dermatitis—Valrubicin—urinary bladder cancer	0.00125	0.00571	CcSEcCtD
Carbachol—Headache—Valrubicin—urinary bladder cancer	0.00125	0.00568	CcSEcCtD
Carbachol—Nausea—Valrubicin—urinary bladder cancer	0.00118	0.00538	CcSEcCtD
Carbachol—Pain—Mitomycin—urinary bladder cancer	0.00117	0.00534	CcSEcCtD
Carbachol—Phlebitis—Etoposide—urinary bladder cancer	0.00117	0.00533	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.00116	0.00528	CcSEcCtD
Carbachol—Hyponatraemia—Cisplatin—urinary bladder cancer	0.0011	0.00503	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.0011	0.00501	CcSEcCtD
Carbachol—Body temperature increased—Mitomycin—urinary bladder cancer	0.00108	0.00493	CcSEcCtD
Carbachol—Necrosis—Methotrexate—urinary bladder cancer	0.00106	0.00482	CcSEcCtD
Carbachol—Abscess—Methotrexate—urinary bladder cancer	0.00105	0.00478	CcSEcCtD
Carbachol—Necrosis—Epirubicin—urinary bladder cancer	0.000991	0.00451	CcSEcCtD
Carbachol—Cramp muscle—Cisplatin—urinary bladder cancer	0.00099	0.00451	CcSEcCtD
Carbachol—Abscess—Epirubicin—urinary bladder cancer	0.000983	0.00448	CcSEcCtD
Carbachol—Stinging—Epirubicin—urinary bladder cancer	0.00096	0.00437	CcSEcCtD
Carbachol—Extravasation—Methotrexate—urinary bladder cancer	0.000953	0.00434	CcSEcCtD
Carbachol—Diarrhoea—Mitomycin—urinary bladder cancer	0.000938	0.00427	CcSEcCtD
Carbachol—Sweating increased—Cisplatin—urinary bladder cancer	0.000926	0.00422	CcSEcCtD
Carbachol—Necrosis—Doxorubicin—urinary bladder cancer	0.000917	0.00418	CcSEcCtD
Carbachol—Abdominal discomfort—Cisplatin—urinary bladder cancer	0.000911	0.00415	CcSEcCtD
Carbachol—Abscess—Doxorubicin—urinary bladder cancer	0.00091	0.00414	CcSEcCtD
Carbachol—Cramp muscle—Etoposide—urinary bladder cancer	0.000907	0.00413	CcSEcCtD
Carbachol—Dizziness—Mitomycin—urinary bladder cancer	0.000906	0.00413	CcSEcCtD
Carbachol—Extravasation—Epirubicin—urinary bladder cancer	0.000892	0.00406	CcSEcCtD
Carbachol—Stinging—Doxorubicin—urinary bladder cancer	0.000888	0.00405	CcSEcCtD
Carbachol—Ulcer—Methotrexate—urinary bladder cancer	0.000879	0.004	CcSEcCtD
Carbachol—Sweating—Gemcitabine—urinary bladder cancer	0.000872	0.00397	CcSEcCtD
Carbachol—Vomiting—Mitomycin—urinary bladder cancer	0.000871	0.00397	CcSEcCtD
Carbachol—Arrhythmia—Thiotepa—urinary bladder cancer	0.000867	0.00395	CcSEcCtD
Carbachol—Rash—Mitomycin—urinary bladder cancer	0.000864	0.00394	CcSEcCtD
Carbachol—Dermatitis—Mitomycin—urinary bladder cancer	0.000863	0.00393	CcSEcCtD
Carbachol—Headache—Mitomycin—urinary bladder cancer	0.000859	0.00391	CcSEcCtD
Carbachol—Sweating increased—Etoposide—urinary bladder cancer	0.000848	0.00386	CcSEcCtD
Carbachol—Extravasation—Doxorubicin—urinary bladder cancer	0.000825	0.00376	CcSEcCtD
Carbachol—Ulcer—Epirubicin—urinary bladder cancer	0.000822	0.00375	CcSEcCtD
Carbachol—Nausea—Mitomycin—urinary bladder cancer	0.000814	0.00371	CcSEcCtD
Carbachol—Hyperkalaemia—Epirubicin—urinary bladder cancer	0.000764	0.00348	CcSEcCtD
Carbachol—Ulcer—Doxorubicin—urinary bladder cancer	0.000761	0.00347	CcSEcCtD
Carbachol—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.000755	0.00344	CcSEcCtD
Carbachol—Arrhythmia—Gemcitabine—urinary bladder cancer	0.000729	0.00332	CcSEcCtD
Carbachol—Arrhythmia—Fluorouracil—urinary bladder cancer	0.000717	0.00326	CcSEcCtD
Carbachol—Hyperkalaemia—Doxorubicin—urinary bladder cancer	0.000707	0.00322	CcSEcCtD
Carbachol—Flushing—Cisplatin—urinary bladder cancer	0.000706	0.00322	CcSEcCtD
Carbachol—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.000699	0.00318	CcSEcCtD
Carbachol—Infection—Thiotepa—urinary bladder cancer	0.000685	0.00312	CcSEcCtD
Carbachol—Arrhythmia—Cisplatin—urinary bladder cancer	0.00068	0.00309	CcSEcCtD
Carbachol—Phlebitis—Epirubicin—urinary bladder cancer	0.000655	0.00299	CcSEcCtD
Carbachol—Flatulence—Cisplatin—urinary bladder cancer	0.000652	0.00297	CcSEcCtD
Carbachol—Flushing—Etoposide—urinary bladder cancer	0.000647	0.00295	CcSEcCtD
Carbachol—Muscle spasms—Cisplatin—urinary bladder cancer	0.000637	0.0029	CcSEcCtD
Carbachol—Dyspepsia—Thiotepa—urinary bladder cancer	0.000607	0.00276	CcSEcCtD
Carbachol—Phlebitis—Doxorubicin—urinary bladder cancer	0.000606	0.00276	CcSEcCtD
Carbachol—Pain—Thiotepa—urinary bladder cancer	0.000589	0.00268	CcSEcCtD
Carbachol—Muscle spasms—Etoposide—urinary bladder cancer	0.000583	0.00266	CcSEcCtD
Carbachol—Infection—Gemcitabine—urinary bladder cancer	0.000576	0.00262	CcSEcCtD
Carbachol—Hyponatraemia—Epirubicin—urinary bladder cancer	0.000567	0.00258	CcSEcCtD
Carbachol—Infection—Fluorouracil—urinary bladder cancer	0.000566	0.00258	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.000565	0.00257	CcSEcCtD
Carbachol—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000561	0.00255	CcSEcCtD
Carbachol—Body temperature increased—Thiotepa—urinary bladder cancer	0.000545	0.00248	CcSEcCtD
Carbachol—Abdominal pain—Thiotepa—urinary bladder cancer	0.000545	0.00248	CcSEcCtD
Carbachol—Hypotension—Gemcitabine—urinary bladder cancer	0.000542	0.00247	CcSEcCtD
Carbachol—Infection—Cisplatin—urinary bladder cancer	0.000537	0.00245	CcSEcCtD
Carbachol—Loss of consciousness—Etoposide—urinary bladder cancer	0.000533	0.00243	CcSEcCtD
Carbachol—Hypotension—Fluorouracil—urinary bladder cancer	0.000533	0.00243	CcSEcCtD
Carbachol—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.000525	0.00239	CcSEcCtD
Carbachol—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000522	0.00238	CcSEcCtD
Carbachol—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000522	0.00238	CcSEcCtD
Carbachol—Asthma—Methotrexate—urinary bladder cancer	0.000521	0.00238	CcSEcCtD
Carbachol—Hypotension—Cisplatin—urinary bladder cancer	0.000505	0.0023	CcSEcCtD
Carbachol—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000502	0.00229	CcSEcCtD
Carbachol—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.0005	0.00228	CcSEcCtD
Carbachol—Pain—Gemcitabine—urinary bladder cancer	0.000496	0.00226	CcSEcCtD
Carbachol—Infection—Etoposide—urinary bladder cancer	0.000492	0.00224	CcSEcCtD
Carbachol—Asthma—Epirubicin—urinary bladder cancer	0.000488	0.00222	CcSEcCtD
Carbachol—Pain—Fluorouracil—urinary bladder cancer	0.000487	0.00222	CcSEcCtD
Carbachol—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000479	0.00218	CcSEcCtD
Carbachol—Diarrhoea—Thiotepa—urinary bladder cancer	0.000472	0.00215	CcSEcCtD
Carbachol—Hypotension—Etoposide—urinary bladder cancer	0.000463	0.00211	CcSEcCtD
Carbachol—Pain—Cisplatin—urinary bladder cancer	0.000462	0.0021	CcSEcCtD
Carbachol—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000458	0.00209	CcSEcCtD
Carbachol—Dizziness—Thiotepa—urinary bladder cancer	0.000456	0.00208	CcSEcCtD
Carbachol—Asthma—Doxorubicin—urinary bladder cancer	0.000452	0.00206	CcSEcCtD
Carbachol—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000451	0.00205	CcSEcCtD
Carbachol—Sweating—Methotrexate—urinary bladder cancer	0.000446	0.00203	CcSEcCtD
Carbachol—Vomiting—Thiotepa—urinary bladder cancer	0.000438	0.002	CcSEcCtD
Carbachol—Rash—Thiotepa—urinary bladder cancer	0.000435	0.00198	CcSEcCtD
Carbachol—Dermatitis—Thiotepa—urinary bladder cancer	0.000434	0.00198	CcSEcCtD
Carbachol—Headache—Thiotepa—urinary bladder cancer	0.000432	0.00197	CcSEcCtD
Carbachol—Body temperature increased—Cisplatin—urinary bladder cancer	0.000427	0.00195	CcSEcCtD
Carbachol—Pain—Etoposide—urinary bladder cancer	0.000423	0.00193	CcSEcCtD
Carbachol—Sweating—Epirubicin—urinary bladder cancer	0.000417	0.0019	CcSEcCtD
Carbachol—Nausea—Thiotepa—urinary bladder cancer	0.000409	0.00186	CcSEcCtD
Carbachol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000397	0.00181	CcSEcCtD
Carbachol—Abdominal pain—Etoposide—urinary bladder cancer	0.000391	0.00178	CcSEcCtD
Carbachol—Body temperature increased—Etoposide—urinary bladder cancer	0.000391	0.00178	CcSEcCtD
Carbachol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00039	0.00178	CcSEcCtD
Carbachol—Sweating—Doxorubicin—urinary bladder cancer	0.000386	0.00176	CcSEcCtD
Carbachol—Dizziness—Fluorouracil—urinary bladder cancer	0.000377	0.00172	CcSEcCtD
Carbachol—Diarrhoea—Cisplatin—urinary bladder cancer	0.00037	0.00168	CcSEcCtD
Carbachol—Vomiting—Gemcitabine—urinary bladder cancer	0.000369	0.00168	CcSEcCtD
Carbachol—Rash—Gemcitabine—urinary bladder cancer	0.000366	0.00166	CcSEcCtD
Carbachol—Dermatitis—Gemcitabine—urinary bladder cancer	0.000365	0.00166	CcSEcCtD
Carbachol—Headache—Gemcitabine—urinary bladder cancer	0.000363	0.00165	CcSEcCtD
Carbachol—Flushing—Epirubicin—urinary bladder cancer	0.000363	0.00165	CcSEcCtD
Carbachol—Vomiting—Fluorouracil—urinary bladder cancer	0.000362	0.00165	CcSEcCtD
Carbachol—Rash—Fluorouracil—urinary bladder cancer	0.000359	0.00164	CcSEcCtD
Carbachol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000359	0.00164	CcSEcCtD
Carbachol—Headache—Fluorouracil—urinary bladder cancer	0.000357	0.00163	CcSEcCtD
Carbachol—Arrhythmia—Epirubicin—urinary bladder cancer	0.000349	0.00159	CcSEcCtD
Carbachol—Nausea—Gemcitabine—urinary bladder cancer	0.000344	0.00157	CcSEcCtD
Carbachol—Vomiting—Cisplatin—urinary bladder cancer	0.000344	0.00156	CcSEcCtD
Carbachol—Rash—Cisplatin—urinary bladder cancer	0.000341	0.00155	CcSEcCtD
Carbachol—Dermatitis—Cisplatin—urinary bladder cancer	0.00034	0.00155	CcSEcCtD
Carbachol—Diarrhoea—Etoposide—urinary bladder cancer	0.000339	0.00154	CcSEcCtD
Carbachol—Nausea—Fluorouracil—urinary bladder cancer	0.000339	0.00154	CcSEcCtD
Carbachol—Flushing—Doxorubicin—urinary bladder cancer	0.000335	0.00153	CcSEcCtD
Carbachol—Flatulence—Epirubicin—urinary bladder cancer	0.000335	0.00153	CcSEcCtD
Carbachol—Dizziness—Etoposide—urinary bladder cancer	0.000327	0.00149	CcSEcCtD
Carbachol—Muscle spasms—Epirubicin—urinary bladder cancer	0.000327	0.00149	CcSEcCtD
Carbachol—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000323	0.00147	CcSEcCtD
Carbachol—Nausea—Cisplatin—urinary bladder cancer	0.000321	0.00146	CcSEcCtD
Carbachol—Vomiting—Etoposide—urinary bladder cancer	0.000315	0.00143	CcSEcCtD
Carbachol—Rash—Etoposide—urinary bladder cancer	0.000312	0.00142	CcSEcCtD
Carbachol—Dermatitis—Etoposide—urinary bladder cancer	0.000312	0.00142	CcSEcCtD
Carbachol—Headache—Etoposide—urinary bladder cancer	0.00031	0.00141	CcSEcCtD
Carbachol—Flatulence—Doxorubicin—urinary bladder cancer	0.00031	0.00141	CcSEcCtD
Carbachol—Syncope—Epirubicin—urinary bladder cancer	0.000305	0.00139	CcSEcCtD
Carbachol—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000303	0.00138	CcSEcCtD
Carbachol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000299	0.00136	CcSEcCtD
Carbachol—Infection—Methotrexate—urinary bladder cancer	0.000295	0.00134	CcSEcCtD
Carbachol—Nausea—Etoposide—urinary bladder cancer	0.000294	0.00134	CcSEcCtD
Carbachol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000287	0.00131	CcSEcCtD
Carbachol—Syncope—Doxorubicin—urinary bladder cancer	0.000282	0.00129	CcSEcCtD
Carbachol—Hypotension—Methotrexate—urinary bladder cancer	0.000277	0.00126	CcSEcCtD
Carbachol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000277	0.00126	CcSEcCtD
Carbachol—Infection—Epirubicin—urinary bladder cancer	0.000276	0.00126	CcSEcCtD
Carbachol—Shock—Epirubicin—urinary bladder cancer	0.000273	0.00124	CcSEcCtD
Carbachol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000268	0.00122	CcSEcCtD
Carbachol—Dyspepsia—Methotrexate—urinary bladder cancer	0.000261	0.00119	CcSEcCtD
Carbachol—Hypotension—Epirubicin—urinary bladder cancer	0.000259	0.00118	CcSEcCtD
Carbachol—Infection—Doxorubicin—urinary bladder cancer	0.000255	0.00116	CcSEcCtD
Carbachol—Pain—Methotrexate—urinary bladder cancer	0.000254	0.00115	CcSEcCtD
Carbachol—Shock—Doxorubicin—urinary bladder cancer	0.000253	0.00115	CcSEcCtD
Carbachol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000248	0.00113	CcSEcCtD
Carbachol—Dyspepsia—Epirubicin—urinary bladder cancer	0.000244	0.00111	CcSEcCtD
Carbachol—Hypotension—Doxorubicin—urinary bladder cancer	0.00024	0.00109	CcSEcCtD
Carbachol—Pain—Epirubicin—urinary bladder cancer	0.000237	0.00108	CcSEcCtD
Carbachol—Abdominal pain—Methotrexate—urinary bladder cancer	0.000234	0.00107	CcSEcCtD
Carbachol—Body temperature increased—Methotrexate—urinary bladder cancer	0.000234	0.00107	CcSEcCtD
Carbachol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000226	0.00103	CcSEcCtD
Carbachol—Pain—Doxorubicin—urinary bladder cancer	0.00022	0.001	CcSEcCtD
Carbachol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000219	0.000999	CcSEcCtD
Carbachol—Abdominal pain—Epirubicin—urinary bladder cancer	0.000219	0.000999	CcSEcCtD
Carbachol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000203	0.000925	CcSEcCtD
Carbachol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000203	0.000925	CcSEcCtD
Carbachol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000203	0.000924	CcSEcCtD
Carbachol—Dizziness—Methotrexate—urinary bladder cancer	0.000196	0.000893	CcSEcCtD
Carbachol—Diarrhoea—Epirubicin—urinary bladder cancer	0.00019	0.000865	CcSEcCtD
Carbachol—Vomiting—Methotrexate—urinary bladder cancer	0.000189	0.000859	CcSEcCtD
Carbachol—Rash—Methotrexate—urinary bladder cancer	0.000187	0.000852	CcSEcCtD
Carbachol—Dermatitis—Methotrexate—urinary bladder cancer	0.000187	0.000851	CcSEcCtD
Carbachol—Headache—Methotrexate—urinary bladder cancer	0.000186	0.000846	CcSEcCtD
Carbachol—Dizziness—Epirubicin—urinary bladder cancer	0.000184	0.000836	CcSEcCtD
Carbachol—Vomiting—Epirubicin—urinary bladder cancer	0.000176	0.000804	CcSEcCtD
Carbachol—Nausea—Methotrexate—urinary bladder cancer	0.000176	0.000802	CcSEcCtD
Carbachol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000176	0.0008	CcSEcCtD
Carbachol—Rash—Epirubicin—urinary bladder cancer	0.000175	0.000797	CcSEcCtD
Carbachol—Dermatitis—Epirubicin—urinary bladder cancer	0.000175	0.000796	CcSEcCtD
Carbachol—Headache—Epirubicin—urinary bladder cancer	0.000174	0.000792	CcSEcCtD
Carbachol—Dizziness—Doxorubicin—urinary bladder cancer	0.00017	0.000773	CcSEcCtD
Carbachol—Nausea—Epirubicin—urinary bladder cancer	0.000165	0.000751	CcSEcCtD
Carbachol—Vomiting—Doxorubicin—urinary bladder cancer	0.000163	0.000744	CcSEcCtD
Carbachol—Rash—Doxorubicin—urinary bladder cancer	0.000162	0.000737	CcSEcCtD
Carbachol—Dermatitis—Doxorubicin—urinary bladder cancer	0.000162	0.000737	CcSEcCtD
Carbachol—Headache—Doxorubicin—urinary bladder cancer	0.000161	0.000733	CcSEcCtD
Carbachol—Nausea—Doxorubicin—urinary bladder cancer	0.000153	0.000695	CcSEcCtD
